Abstract
Thrombosis is a multifactorial disorder. Congenital disorders of glycosylation (CDG) are one of the known risk factors for its occurrence. These disorders result in glycosylation defects of glycoproteins, including those of the (anti-)coagulation system. CDG-Ib can specifically be treated with mannose, as illustrated by the case of a 4-year-old girl in whom deep venous thrombosis was the presenting symptom after a common viral infection. The diagnosis was made after recurrent episodes of thrombo-embolism and consumptive coagulopathy. After treatment with mannose no such episodes recurred. The pathophysiology of CDG as a risk factor for thrombotic disease is discussed.
Original language | English |
---|---|
Article number | 906491636 |
Pages (from-to) | 762-768 |
Number of pages | 7 |
Journal | Pediatric hematology and oncology |
Volume | 25 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2008 |
Keywords
- CDG
- coagulopathy
- congenital disorder of glycosylation
- Jaeken syndrome
- mannose
- thrombosis
- DEFICIENT GLYCOPROTEIN SYNDROME
- PHOSPHOMANNOSE ISOMERASE DEFICIENCY
- COAGULATION ABNORMALITIES
- HYPOGLYCEMIA